Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance database

Eur Respir J. 2018 Jan 11;51(1):1701855. doi: 10.1183/13993003.01855-2017. Print 2018 Jan.

Bruno Revol^{1

2

3}, Ingrid Jullian-Desayes^{1

2}, Sébastien Bailly^{1

2}, Michel Mallaret³, Renaud Tamisier^{1

2}, Marie-Sara Agier⁴, Frédéric Lador⁵, Marie Joyeux-Faure^{1

2

6}, Jean-Louis Pépin^{7

2

6}

¹ HP2 laboratory, Inserm U1042 unit, University Grenoble Alps, Grenoble, France.
² EFCR laboratory, Thorax and Vessels, Grenoble Alps University Hospital, Grenoble, France.
³ Pharmacovigilance Dept, Grenoble Alps University Hospital, Grenoble, France.
⁴ Pharmacovigilance Dept, Tours University Hospital, Tours, France.
⁵ Sleep Laboratory and Division of Pulmonology, Dept of Medicine Specialties, Geneva University Hospitals, Geneva, Switzerland.
⁶ These authors contributed equally to this work.
⁷ HP2 laboratory, Inserm U1042 unit, University Grenoble Alps, Grenoble, France JPepin@chu-grenoble.fr.

No abstract available

Publication types